Bantamweight Champ TJ Dillashaw Gives Neil Riordan, PA, PhD a Shout-out at UFC 227

And Still…!!

Congratulations UFC Bantamweight Champion and Stem Cell Institute Patient TJ Dillashaw. Thanks for giving Dr. Riordan a shout out in the ring on live TV after your impressive championship defense over Cody Garbrandt!

Do “Golden Cells” at Stem Cell Institute in Panama work?  Ask The Champ!

(The shout out occurs around 1:50)

Dr. Riordan on the Umbilical Cord Selection Process at Stem Cell Institute

“Through retrospective analysis of our cases, we’ve identified proteins and genes that allow us to screen several hundred umbilical cord donations to find the ones that we know are most effective. We only use these cells and we call them ‘golden cells’.

We go through a very high throughput screening process to find cells that we know have the best anti-inflammatory activity, the best immune modulating capacity, and the best ability to stimulate regeneration.”

Stem Cell Therapy in Panama Motivates Tony Robbins, NY Times #1 Best-selling Author!

Image of Motivational Speaker Tony Robbins at Stem Cell Institute in Panama

“Feeling absolutely invigorated after our trip to Panama this weekend, where I received the transformative benefits of stem cell therapy! Our huge thanks and honor to all the doctors and the bright, caring medical staff at the state-of-the-art Stem Cell Institute in Panama City, Panama 🇵🇦. Stem cells saved my shoulder after struggling with excruciating pain from spinal stenosis and, more recently, a torn rotator cuff. Stem cell treatment is truly a next-level health innovation that can reverse the wear and tear we put on our bodies and prevent debilitating disease and injury from escalating further 🔬. This technological advancement will impact humanity in life-changing ways— it has the potential to transform and save MILLIONS of lives!…”  View Original Instagram Post
.

Read Dr. Riordan’s Amazon #1 best-selling book about stem cell therapy today

“Neil takes readers on a riveting journey through the past, present and future of stem cell therapy. His well-researched, educational and entertaining book could change your life. I highly recommend it.”Tony Robbins, NY Times #1 Bestselling Author 

Image of Stem Cell Therapy - A Rising Tide Book Cover

Stem cells are the repair cells of your body. When there aren’t enough of them, or they aren’t working properly, chronic diseases can manifest and persist.

Neil H Riordan, PA, PhD, author of MSC: Clinical Evidence Leading Medicine’s Next Frontier, the definitive textbook on clinical stem cell therapy, brings you an easy-to-read book about how and why stem cells work, and why they’re the wave of the future.

From industry leaders, sport stars, and Hollywood icons to thousands of everyday, ordinary people, stem cell therapy has helped when standard medicine failed. Many of them had lost hope. These are their stories.

Purchase

UFC Champion TJ Dillashaw discusses how stem cell therapy in Panama cleared up his psoriasis

UFC bantamweight World Champion TJ Dillashaw discusses a side effect of his stem cell treatment at Stem Cell Institute in Panama with its founder, Neil Riordan, PA, PhD during dinner in Panama.

Dr. Riordan – I am talking about the last time you were down here.

TJ – I’ve been learning a lot about what the stem cell therapy did for me. Stuff that I didn’t even know it was going to do until I listened to you on the [Joe Rogan] podcast [with Mel Gibson]. And one was it got rid of my psoriasis.

Dr. Riordan – And where was your psoriasis?

TJ – My scalp. I had it for like six years. I thought changing my diet and all this stuff would help it out but I think what really helped it was coming down and getting stem cells.

Dr. Riordan – And how long was it after you got treated that you felt the difference?

TJ – Shoot. I didn’t notice for probably a couple months, I think is when I figured it out. I had it really bad but a couple months later it was completely gone.

Dr. Riordan – Wow.

TJ – I had it for six years, you know? Yeah.

Treatment with Umbilical Cord Stem Cells Safe with Sustained Benefits for MS, Trial Shows

Image of GMP syringe prep lab at Stem Cell Institute clinic in Panama.

Stem cells being prepared for treatment.

March 20, 2018
Jose Marques Lopes, PhD
Link to Original Story at Multiple Sclerosis News Today

Treatment with umbilical cord [tissue-derived mesenchymal] stem cells was found to be safe and leads to sustained improvements in disability and brain lesions of multiple sclerosis (MS) patients, according to a clinical trial.

The study, “Clinical feasibility of umbilical cord tissue-derived mesenchymal stem cells in the treatment of multiple sclerosis,” was published in the Journal of Translational Medicine.

Although current treatments for MS are able to reduce the frequency of flare-ups and slow disease progression, they are not able to repair the damage to nerve cells or the myelin sheath, the protective layer around nerve fibers.

Mesenchymal stem cells (MSCs) are adult stem cells found in multiple tissues, such as umbilical cord, bone marrow, and fat. These cells are able to mature into bone, cartilage, muscle, and adipose tissue cells.

MSCs may inhibit immune-mediated alterations. In particular, MSCs derived from the umbilical cord have a high ability to grow and multiply, increase the production of growth factors, and possess superior therapeutic activity, compared with other MSCs.

Diverse clinical studies have shown that MSCs can safely treat certain immune and inflammatory conditions, including MS.

The research team had previously demonstrated that MSCs can also improve cognitive and motor function.

Recent results with placenta or umbilical cord MSCs showed few mild or moderate adverse events, as well improvements in patients’ level of disability.

Researchers at the Stem Cell Institute in Panama have now completed a one-year Phase 1/2 clinical study (NCT02034188) to test the effectiveness and safety of umbilical cord MSCs for the treatment of MS.

The trial included 20 MS patients with a mean age of 41 years, 60 percent of whom were women. Fifteen participants had relapsing-remitting MS, four had primary progressive MS, and one had secondary progressive MS. Patients’ disease duration was a mean of 7.7 years.

Participants received seven intravenous infusions of 20×106 umbilical cord MSCs over seven days. The treatment’s effectiveness was evaluated at the start, at one month, and at one year after treatment.

Assessments included evaluating brain lesions with magnetic resonance imaging (MRI) and disability based on the Kurtzke Expanded Disability Status Scale (EDSS), as well as validated MS tests for neurological function, hand function, mobility, and quality of life.

Patients did not report any serious adverse events. Most mild adverse events possibly related to treatment were headaches, which are common after MSC infusions, and fatigue, which is common in MS patients, the authors observed.

Improvements were most evident at one month after treatment, namely in the level of disability, nondominant hand function, and average walk time, as well as bladder, bowel, and sexual dysfunction. Patients also reported improved quality of life.

MRI scans at one year after treatment revealed inactive lesions in 15 of 18 evaluated patients. One patient showed almost complete elimination of lesions in the brain, which “is a particularly encouraging finding,” the researchers wrote.

At the one year point, improvements in disability levels were also still present, and could translate into improved ability to walk and work without assistance.

“The potential durable benefit of UCMSC [umbilical cord MSC] at 1 month, and sustained in some measures to 1 year, is in stark contrast to current MS drug therapies, which are required to be taken daily or weekly,” the researchers wrote.

The safety of the treatment is another advantage over available MS therapies, the team said.

They concluded that “treatment with UCMSC intravenous infusions for subjects with MS is safe, and potential therapeutic benefits should be further investigated.”

Podcast: Listen to Dr. Mike Hutchinson, DVM interview with Dr. Riordan about stem cell therapy

About This Episode

Delve deeper into the stem cell world with pioneer and expert Dr. Neil Riordan. Co-founder/chief science officer of the Riordan-McKenna Institute, founder/chairman/chief science officer of the Stem Cell Institute and author of Stem Cell Therapy: A Rising Tide, he’s here to discuss ongoing stem cell studies with Duchenne Muscular Dystrophy, spinal cord injuries, MS, autism and more. He’ll also answer one of the most common stem cell questions: how can one cell treat so many different conditions?

View on drmikehutchinson.com

Video: Stem Cell Therapy in Panama with Dr. Riordan and Mel Gibson

Host Michael Beattie discusses stem cell therapy using *human umbilical cord tissue-derived mesenchymal stem cells (hUCT-MSCs)  at the Stem Cell Institute in Panama with renowned applied stem cell scientist and founder, Neil Riordan, Pa, PhD and acclaimed actor, director and producer Mel Gibson.

Dr. Riordan discusses the miraculous progress of a spinal cord injury patient and pilot whose doctors said that he would never walk again.  He talks about where the stem cells come from, how they work and why they can treat so many seemingly different conditions.  Dr. Riordan explains how umbilical cords, and subsequently, hUCT-MSCs used at the Stem Cell Institute are carefully selected using molecular screening.  He also discusses why mesenchymal stem cells from umbilical cords function better than MSCs from adults, especially as they age or if they are suffering from a disease like multiple sclerosis.  For example. MSCs from a newborn multiply exponentially compared to MSCs from an older adult.

Mel Gibson discusses his father’s miraculous recovery, literally from his deathbed after receiving hUCT-MSCs at the age of 92.  He’s currently 99 and still going strong having been treated in Panama several times since then.  Mel also discusses his personal experiences in Panama.

Watch all this and more.

*umbilical cord tissue harvested after normal, healthy births

Stem Cell Therapy for Autism: John Guerriero Interview with Neil Riordan, PhD, PA

John Guerriero discusses the progress of his son Anthony with Neil Riordan, PhD, PA after undergoing stem cell therapy at the Stem Cell Institute in Panama City, Panama. Anthony was treated with human umbilical cord-derived mesenchymal stem cells. The umbilical cords were donated by mothers following normal, healthy births.

Stem Cell Thearpy for Autism – Interview with Stephen Lallo and Neil Riordan, PhD, PA

Stephen Lallo discusses his son Jack’s improvements after undergoing stem cell therapy at the Stem Cell Institute in Panama City, Panama. The treatments us human umbilical cord tissue-derived mesenchymal stem cells. The umbilical cords are donated by mothers following normal, healthy births.

Stem Cell Therapy at Stem Cell Institute on PBS-TV Dallas-Fort Worth this Sunday! PBS KERA TV-13

Brenda Watson Show. KERA
PBS TV (KERA 13) in Dallas-Fort Worth – Go inside our clinic and lab in Panama, and watch interviews with 3 patients. The other episode follows a knee patient through the treatment process at Dr. RIordan’s orthopedic stem cell clinic in Southlake, Texas. Sunday, January 29th from 12pm – 1pm.

Stem Cells I

Riordan-McKenna Institute – Stem Cell Therapy for Orthopedics

Take a journey with marathon runner and knee patient Jim Morella as he undergoes a stem cell augmented arthroscopic knee procedure. Peer inside the operating room as Dr. McKenna harvests stem cells from Jim’s bone marrow, prepares them, and injects them into his knee. Tag along with Brenda as she interviews Jim at home following his recovery.

Dr. McKenna discusses Jim’s case with Brenda and explains why stem cell injections alone are not necessarily the best solution to knee problems, including Jim’s. He also touches upon the FDA’s current role regarding regulations.

Dr. Riordan talks about how the proprietary amniotic membrane tissue product used by RMI can enhance bone marrow stem cell therapy and the safety aspects of such treatments.

Dr. McKenna Stem Cell Augmented Surgery 3

Stem Cells II

Stem Cell Institute in Panama: Spinal Cord Injury, Multiple Sclerosis (MS), Rheumatoid Arthritis (RA) and More…

Brenda Watson takes you inside the Stem Cell Institute and Medistem Labs in Panama. If you have ever wondered what stem cell therapy is like in Panama, this show is for you.

See inside the laboratory and clinic as Brenda follows three patients through the treatment and recovery process: Sam Harrell (MS), Juan Jose Ballareno (Spinal Cord Injury) and Todd Rinehart (RA).

Meet the team as she interviews key players:

Neil Riordan, PhD, Founder and Chief Scientist of Medistem Labs, explains how the Panamanian government regulates stem cells in Panama. He discusses how HUCT-MSCs work on RA before delving into the subject of clinical trials in Panama and the USA.

Medical director, Jorge Paz Rodriquez, MD discusses how HUCT-MSCs work and why they can be transplanted without immune system rejection.

Rodolfo Fernandez, Medistem Panama Laboratory Director talks about tissue selection and processing.